Kalehua Capital Management LLC
DALLAS TX · SEC CIK 0002106181
$2.60亿2026Q1 申报市值
25持仓数
72.1%前十大占比 · 第一大 15.1%
9 / 3新建仓 / 清仓
26Q126Q2
前十大持仓 占组合比例
2026Q1 买入最多 按季末市值估算
MANE 新建仓+$1,569.74万
XFOR 加仓+$1,537.53万
BOXX 加仓+$1,231.66万
ACRS 新建仓+$1,188.72万
SRZN 加仓+$1,122.02万
2026Q1 卖出最多 按季末市值估算
ALLO 清仓-$348.82万
ORIC 清仓-$218.45万
Verrica Pharmace 清仓-$195.93万
2026Q1 持仓明细 点表头排序
导出 CSV 🔒| 代码 | 名称 | 市值 ▲ | 占比 | 股数 | 变动股数 | 变动 | 估算买卖额 | 操作 |
|---|---|---|---|---|---|---|---|---|
| ALLO | Allogene Therapeutics Inc | $0 | 0.00% | 0 | -2,546,129 | -100.0% | -$348.82万 | 清仓 |
| ORIC | Oric Pharmaceuticals Inc | $0 | 0.00% | 0 | -267,059 | -100.0% | -$218.45万 | 清仓 |
| — | Verrica Pharmaceuticals Inc | $0 | 0.00% | 0 | -235,779 | -100.0% | -$195.93万 | 清仓 |
| — | LONGEVERON INC | $36.14万 | 0.14% | 347,539 | 347,539 | — | $36.14万 | 新建仓 |
| — | DiaMedica Therapeutics Inc | $84.61万 | 0.33% | 124,976 | 29,617 | 31.1% | $20.05万 | 加仓 |
| KRRO | KORRO BIO INC | $123.81万 | 0.48% | 109,376 | 109,376 | — | $123.81万 | 新建仓 |
| — | Kalaris Therapeutics Inc | $156.47万 | 0.60% | 271,170 | 131,269 | 93.8% | $75.74万 | 加仓 |
| — | Instil Bio Inc | $266.05万 | 1.02% | 322,879 | 322,879 | — | $266.05万 | 新建仓 |
| — | Tenaya Therapeutics Inc | $276.96万 | 1.07% | 4,000,000 | 2,000,000 | 100.0% | $138.48万 | 加仓 |
| — | PepGen Inc | $306.20万 | 1.18% | 1,729,961 | 1,729,961 | — | $306.20万 | 新建仓 |
| TYRA | Tyra Biosciences Inc | $570.40万 | 2.19% | 148,930 | 74,465 | 100.0% | $285.20万 | 加仓 |
| — | Gossamer Bio Inc | $581.71万 | 2.24% | 17,708,133 | 17,708,133 | — | $581.71万 | 新建仓 |
| MLTX | MoonLake Immunotherapeutics | $655.14万 | 2.52% | 351,468 | 175,734 | 100.0% | $327.57万 | 加仓 |
| DMRA | Damora Therapeutics Inc | $720.02万 | 2.77% | 278,000 | 278,000 | — | $720.02万 | 新建仓 |
| — | LeonaBio Inc | $809.45万 | 3.11% | 787,402 | 393,701 | 100.0% | $404.72万 | 加仓 |
| QURE | Uniqure NV | $822.10万 | 3.16% | 502,811 | 502,811 | — | $822.10万 | 新建仓 |
| CMPS | Compass Pathways PLC | $906.58万 | 3.49% | 1,639,384 | 819,692 | 100.0% | $453.29万 | 加仓 |
| SEPN | Septerna Inc | $934.98万 | 3.60% | 389,088 | 194,544 | 100.0% | $467.49万 | 加仓 |
| IKT | Inhibikase Therapeutics Inc | $1,091.08万 | 4.20% | 6,494,498 | 4,744,498 | 271.1% | $797.08万 | 加仓 |
| PHVS | Pharvaris NV | $1,123.06万 | 4.32% | 397,544 | 198,772 | 100.0% | $561.53万 | 加仓 |
| ORKA | Oruka Therapeutics Inc | $1,162.72万 | 4.47% | 237,048 | 118,524 | 100.0% | $581.36万 | 加仓 |
| ACRS | ACLARIS THERAPEUTICS INC | $1,188.72万 | 4.57% | 3,169,921 | 3,169,921 | — | $1,188.72万 | 新建仓 |
| MANE | Veradermics Inc | $1,569.74万 | 6.04% | 248,574 | 248,574 | — | $1,569.74万 | 新建仓 |
| SION | Sionna Therapeutics Inc | $1,580.12万 | 6.08% | 394,144 | 197,072 | 100.0% | $790.06万 | 加仓 |
| RLAY | Relay Therapeutics Inc | $1,793.90万 | 6.90% | 1,802,914 | 901,457 | 100.0% | $896.95万 | 加仓 |
| SRZN | Surrozen Inc | $2,244.05万 | 8.63% | 770,356 | 385,178 | 100.0% | $1,122.02万 | 加仓 |
| XFOR | X4 Pharmaceuticals Inc | $3,075.07万 | 11.83% | 7,445,680 | 3,722,840 | 100.0% | $1,537.53万 | 加仓 |
| BOXX | Alpha Architect 1-3 Month Box ETF | $3,915.48万 | 15.06% | 336,700 | 105,913 | 45.9% | $1,231.66万 | 加仓 |